Last week, readers were most interested in a story about Baebies' multifunctional POC system that offers molecular testing alongside another test modality.

While the effort could bring new requirements to the reimbursement process, it could also make payments more standardized and ...

The researchers measured ctDNA in women with breast cancer over 70 years of age before beginning endocrine therapy and ...

The oversubscribed round will support final assay development and manufacturing readiness for an early access program launch.

The platform enables collection of breath samples from the deep lung while eliminating contamination from the mouth, upper airways, and environment.

The study included 3,014 patients evaluated based on high-risk screening, symptomatic presentation, or identification of a mass on imaging.

Intended to assist biopharma developers of companion assays, the partnership follows one for clinical trial support the firms announced last year.

The clinical trial is designed to catch cancer at its earliest molecular signal and intervene before it becomes metastatic.

The firm also announced its Q4 and full-year 2025 financial results, reporting that revenues for the year doubled compared to 2024.

Clinical labs are exploring new business opportunities as consumers take more control of their healthcare and bypass their ...

Cepheid's GeneXpert system displayed at a conference. NEW YORK – A decade ago, a molecular point-of-care test received CLIA waiver for the first time, ushering in what many thought would be a seismic ...

The money will be used to procure and administer 20/20 BioLabs' OneTest blood-based MCED assay to more than 1,400 firefighters. The funding comes from Maryland's Professional and Volunteer Firefighter ...